2006 Conference Publication Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patientsHennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Pharmacokinetic study of itraconazole leads to new improved dosing regimens for paediatric cystic fibrosis and bone marrow transplant patients. The 6th Annual Health and Medical Research Conference of Queensland, Brisbane, Australia, 23-24 November 2006. Brisbane, Australia: Queensland Health. |
2006 Conference Publication A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosisHennig, S., Wainwright, C. E., Bell, S., Miller, H., Charles, B. G. and Duffull, S. B. (2006). A D-optimal designed population pharmacokinetic study of itraconazole capsules and solution in adults with cystic fibrosis. 15th Annual Meeting of the Population Approach Group in Europe, Bruges, Belgium, 14-16 June 2006. PAGE. |
2006 Journal Article Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patientsHennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Clinical Pharmacokinetics, 45 (11), 1099-1114. doi: 10.2165/00003088-200645110-00004 |
2006 Conference Publication Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT)Hennig, S, Wainwright, C E, Bell, S, Miller, H, Friberg, L. E. and Charles, B G (2006). Paediatric population pharmacokinetcis (popPK) of itraconazole (ITRA) and its active metabolite hydroxy-itraconazole in cystic fibrosis (CF) and bone marrow transplant patients (BMT). PAGANZ 06 9th Annual Scientific Meeting, Auckland New Zealand / School of Medicine, 7-9 February 2006. Brisbane, Australia: Poppulation Approach Group in Australia and New Zealand. |
2006 Book Chapter Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future ManagementJones, A. M. and Bell, S. C. (2006). Cystic Fibrosis Infection with Clonal Strains of Pseudomonas Aeruginosa: Current Knowledge and Future Management. Cystic Fibrosis. (pp. 105-126) edited by K. Webb and F. Ratjen. London: Maney Publishing. |
2006 Conference Publication Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patientsHennig, S., Wainwright, C. E., Bell, S. C., Miller, H., Friberg, L. E. and Charles, B. G. (2006). Paediatric population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in cystic fibrosis and bone marrow transplant patients. Population Approach Group Europe: 15th Meeting, Bruges, Belgium, 14-16 June 2006. PAGE. |
2005 Journal Article Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditionsHill, Dominic, Rose, Barbara, Pajkos, Aniko, Robinson, Michael, Bye, Peter, Bell, Scott C., Elkins, Mark, Thompson, Barbara, MacLeod, Colin, Aaron, Shawn D. and Harbour, Colin (2005). Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. Journal of Clinical Microbiology, 43 (10), 5085-5090. doi: 10.1128/JCM.43.10.5085-5090.2005 |
2005 Journal Article MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?Downey, D. G., Kidd, T. J., Coulter, C. and Bell, S. C. (2005). MRSA eradication in a health care worker with cystic fibrosis; re-emergence or re-infection?. Journal of Cystic Fibrosis, 4 (3), 205-207. doi: 10.1016/j.jcf.2005.05.014 |
2005 Journal Article Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosisBuntain, Helen M., Greer, Ristan M., Wong, Joseph C.H., Schluter, Philip J., Batch, Jennifer, Lewindon, Peter, Bell, Scott C. and Wainwright, Claire E. (2005). Pubertal development and its influences on bone mineral density in Australian children and adolescents with cystic fibrosis. Journal of Paediatrics And Child Health, 41 (7), 317-322. doi: 10.1111/j.1440-1754.2005.00635.x |
2005 Journal Article Has the time come to prescribe azithromycin in cystic fibrosis patients?McCormack, J. G. and Bell, S. C. (2005). Has the time come to prescribe azithromycin in cystic fibrosis patients?. Internal Medicine Journal, 35 (2), 73-74. doi: 10.1111/j.1445-5994.2004.00762.x |
2005 Conference Publication Antibiotics for acute exacerbations of COPD: A systematic reviewYang, I. A., Kim, S. T. and Bell, S. C. (2005). Antibiotics for acute exacerbations of COPD: A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1 |
2005 Conference Publication The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolatesSemple, K., Senini, S., Serisier, D., Bowler, S., Bell, S. and McCormack, J. (2005). The effect of mucoidy on biofilm formation in cystic fibrosis clinical isolates. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1 |
2005 Conference Publication A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An updateBurrows, J., Nissen, L. M., Kirkpatrick, C. M. J. and Bell, S. C. (2005). A study of desensitisation procedures to beta-lactam antibiotics in adult patients with cystic fibrosis: An update. Sixth Australian & New Zealand Cystic Fibrosis Conference, Adelaide, 20-23 Aug. 2005. Australia: |
2005 Conference Publication Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotypeKim, S. T., Passmore, L., Dent, A. G., Slaughter, R., Yang, I. A., Fong, K. M., Zimmerman, P. V. and Bell, S. C. (2005). Gender difference in prevalence of non-cystic fibrosis bronchiectasis (NCFB) does not influence clinical phenotype. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1 |
2005 Conference Publication Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosisKermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 28th European Cystic Fibrosis Conference, Crete, Greece, 22-25 June 2005. Amsterdam, Netherlands: Elsevier BV. doi: 10.1016/S1569-1993(05)80113-4 |
2005 Journal Article Macrolides in cystic fibrosisBell, S. C., Senini, S. L. and McCormack, J. G. (2005). Macrolides in cystic fibrosis. Chronic Respiratory Disease, 2 (2), 85-98. doi: 10.1191/1479972305cd066rs |
2005 Conference Publication Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosisKermeen, F. D., Kim, S. T., Kidd, T. J., Coulter, C., Greer, R. M. and Bell, S. C. (2005). Transient non-genomovar III Burkholderia cepacia infection is not uncommon in adults with cystic fibrosis. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, WA, Australia, 18-23 March 2005. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1 |
2005 Conference Publication Antibiotics in cystic fibrosis (CF): A systematic reviewKim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. 2005 Annual Scientific Meeting The Thoracic Society of Australia and New Zealand, Perth, Australia, 18-23 March, 2005. Carlton South, Victoria: Blackwell Publishing Asia. doi: 10.1111/j.1440-1843.2005.00663.x-i1 |
2005 Conference Publication Antibiotics in cystic fibrosis (CF): A systematic reviewKim, S. T., Yang, I. A. and Bell, S. C. (2005). Antibiotics in cystic fibrosis (CF): A systematic review. Array, Crete, Greece, 22-25 Jun, 2005. Amsterdam, Netherlands: Elsevier BV. |
2005 Journal Article Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trialAaron, Shawn D., Vandemheen, Katherine L., Ferris, Wendy, Fergusson, Dean, Tullis, Elizabeth, Haase, David, Berthiaume, Yves, Brown, Neil, Wilcox, Pearce, Yozghatlian, Veronica, Bye, Peter, Bell, Scott, Chan, Francis, Rose, Barbara, Jeanneret, Alphonse, Stephenson, Anne, Noseworthy, Mary, Freitag, Andreas, Paterson, Nigel, Doucette, Steve, Harbour, Colin, Ruel, Michel and MacDonald, Noni (2005). Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multi-resistant bacteria: A randomised, double-blind, controlled clinical trial. The Lancet, 366 (9484), 463-471. doi: 10.1016/S0140-6736(05)67060-2 |